Abstract Despite substantial advances in the diagnosis of cardiovascular disease, 18
Introduction
Since the 1980s, single photon emission computed tomography (SPECT) has played a key role in assessing myocardial blood flow (MBF) and in diagnosing coronary artery disease (CAD) [1] [2] [3] . Notably, SPECT agents such as 99m Tcsestamibi, 99m Tc-tetrofosmin, or 201 Tl are the mainstay of myocardial perfusion imaging (MPI) [4, 5] . However, the technical limitations of SPECT imaging, such as the absence of a standardized method for correction of photon attenuation and significant uptake of SPECT tracers in organs adjacent to the heart, may compromise the delineation of small lesions and limit the diagnostic accuracy of SPECT [6] . Positron emission tomography (PET) has several technical advantages over SPECT. Not only does PET imaging have higher spatial resolution and a standardized method for the correction of photon attenuation, but PET also enables quantitative measurements of MBF because it allows for accurate determination of rapidly changing tissue counts over time. Therefore, PET allows for quantitative measures of myocardial tracer uptake and regional MBF [7, 8] . However, the PET tracers currently used for MPI have a short half-life ( 13 N-NH 3 : 9.97 min; 82 Rb: 1.27 min; 15 O-H 2 O: 2.04 min), which limits widespread clinical use of PET because of the need for an onsite cyclotron or generator [9, 10] . Thus, use of a radioisotope that has proper half-life for clinical use to label myocardial perfusion agents could overcome these limitations and simplify clinical protocols [7, 11] .
The Rationale for 18 
F-Labeled Tetraphenylphosphonium Cation Derivatives
The mitochondrial membrane potential (MMP) is higher in cardiomyocytes than in normal epithelial cells, and loss of MMP is an early event in cell death caused by myocardial ischemia [12, 13] . Similar to SPECT agents such as 99m Tcsestamibi and 99m Tc-tetrofosmin, tetraphenylphosphonium cation (TPP) derivatives penetrate the hydrophobic barriers of the plasma and mitochondrial membranes and accumulate in mitochondria of cardiomyocytes [14] [15] [16] [17] [18] . This accumulation occurs because the 99m Tc-sestamibi, 99m Tc-tetrofosmin, and TPP derivatives move into mitochondrium in response to its high density and the negative inner transmembrane potentials (−150 to −170 mV, negative inside) in cardiomyocytes [17] . Therefore, radiolabeled TPP derivatives are promising candidates for myocardial imaging [19, 20] . Table 1 shows the radiolabeled TPP derivatives that have been developed [15, 16, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] . The chemical structures of radiolabeled TPP derivatives are shown in Fig. 1 . Among them, the first reported was 11 Ctriphenylmethylphosphonium cation ( 11 C-TPMP), which serves as a mitochondrial membrane voltage sensor detectible via PET [21] . However, 11 C-TPMP use is limited to use widely because of the short half-life of 11 C (20 min) despite good in vivo characteristics. To provide a tracer similar to 11 C-TPMP but with a longer half-life, the synthesis and evaluation of 18 18 F-FBnTP showed promise as a myocardial perfusion agent. 18 F-FBnTP is metabolically stable and performs well as a cardiac imaging agent in healthy and CAD models [15, 16, 27] . In a separate study, direct fluorination of TPP was investigated [23] . However, these 18 F-labeled tracers needed improved in vivo characteristics, such as higher uptake and longer retention of tracer in the heart and more rapid wash out from liver to be used as myocardial imaging agents. Thus we developed novel 18 F-labeled tetraphenylphosphonium cation derivatives, fluoroalkyltriphenylphosphonium cations (FATPs). Alkyl chain conjugated triphenylphosphonium cation, have improved characteristics through lipophilicity control [28] [29] [30] [31] [32] .
Myocardial selectivity and hepatic clearance depend on the lipophilicity and functional groups of the radiotracer. Although little is known regarding the optimal lipophilicity needed for high myocardial selectivity, cationic radiotracers with log P values in the range of 0.5-1.3 are particularly useful for imaging organs with high mitochondrial density, as a result of their fast membrane-penetration kinetics [36] . Furthermore, the lipophilic interaction between the triphenylphosphonium cation and the lipid layer is attractive because the alkyl group increases lipophilicity [38, 39] .
Radiosynthesis of 18 
We described radiolabeling procedures of representative radiolabeled phosphonium salts including 11 C-TPMP, 18 F-labeled TPP, 18 F-labeled TPP derivatives and 18 F-labeled (Fig. 2) [23] [24] [25] . The first method used 4-nitrophenyltriphenylphosphonium as the 18 F-labeling precursor for a one step nucleophilic substitution reaction. This precursor was prepared first by following the procedure of Rieke et al. [40] . The diazonium chloride intermediate was formed by slowly adding hydrochloric acid to 4-nitroaniline. The formation of 4-nitrophenyltriphenylphosphonium was obtained by the addition of triphenylphosphine to the diazonium chloride intermediate, which was then extracted in aqueous solution and precipitated with sodium iodide (NaI) to generate the pure precursor. Cheng used potassium carbonate (K 2 CO 3 ) and the phase transfer agent Kryptofix 222, and Shoup used ammonium hydroxide after counter ion exchange of 4-nitrophenyltriphenylphosphonium changed nitrate with 18 F for labeling [23, 25] . The second method used 4-iodophenyltrimethylammonium iodide as a precursor [24] . After 18 F-labeling of 4-iodophenyltrimethylammonium iodide, 1-18 F-fluoro-4-iodobenzene was made to react with triphenylphosphine to yield the final labeled compound. The RCY of the two methods was 10-15 % and the specific activity was >18.5 TBq/mmol at the end of synthesis. The total synthesis time was less than 60 minutes, and the radiochemical purity above 95 %. 18 F-labeling of TPP derivatives was reported by Ravert et al. He created a functional group between the triphenylphosphonium and 18 F [37] . The radiosynthesis of 3-18 F- fluoropropyltriphenylphosphonium cation was performed in a single vessel. After drying the nca 18 F in the presence of Kryptofix and K 2 CO 3 , propylene glycol ditosylate in acetonitrile was added and the solution heated. Triphenylphosphine in toluene was added subsequently. After the solution was heated to boiling, the toluene evaporated and purified by high pressure liquid chromatography (HPLC). They used 0.1 M ammonium formate as an HPLC eluent, but a buffer change was needed, such as injectable water, saline or phosphate buffer saline to use the cation for in vivo experiments due to the toxicity of ammonium formate. The synthesis, purification and formulation were completed in 56 minutes (n = 10). The RCY was 12 % (non-decay corrected) and the specific activity was 15.5 GBq/μmol.
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The radiosynthesis of 18 F-FBnTP was more complicated than that of the (3-18 F-fluoropropyl)triphenylphosphonium cation. 18 F-FBnTP was synthesized using a four-step procedure. As a precursor, 4-trimethylammoniumbenzaldehyde was used to create a third intermediate, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] F-fluorobenzyl bromide, which was reacted with triphenylphosphine to yield 18 F-FBnTP. Finally, 18 F-FBnTP was purified using a preparative HPLC system. A radiochemically pure product (>99 %) was obtained with a 6 % yield (non-decay corrected) with an average synthesis time of 82 minutes (n = 20) and a specific radioactivity of 16.7 GBq/μmol. The r a d i os y nt h e s i s o f t he 4 -1 8 F -f l u or ob e nz yl t r i s -4 -dimethylaminophenylphosphonium cation was performed in the same manner as the 4 −18 F-FBnTP described above except that tris-dimethylaminophosphine was substituted for triphenylphosphine in the last synthetic step. The radiochemically pure radioproduct (>99 %) was obtained with a 15 % yield (non-decay corrected) with an average synthesis time of 80 minutes (n = 6) and an average specific radioactivity of 12. F labeling method using 4-nitrophenyltriphenylphosphonium b Two step 18 F labeling method using 4-iodophenyltrimethylammonium iodide range of lipophilicity suitable for PET myocardial imaging agents. 18 F-FATPs were prepared as described previously [28] [29] [30] [31] [32] . It took a total reaction time of less than 60 minutes for 18 F-FATPs to be ready for tracer injection. A radiochemically pure radioproduct (>98 %) was obtained with a 10-20 % yield (non-decay corrected) and the average specific radioactivity was >5.9 Tbq/μmol.
Biodistribution studies of 18 
F-Labeled Tetraphenylphosphonium Cation Derivatives
Biodistribution results of radioisotope labeled TPP derivatives are summarized in Table 2. 14 C-TPMP distribution was evaluated in mice and rats. 14 C-TPMP had maximum cardiac uptake two minutes after injection (16.53 ± 1.90 % ID/g) in mice and its level remained nearly constant for 60 min. The heartto-blood ratios were 31, 54, 86, and 153 at 2, 10, 30, and 60 min, respectively. The small intestine, liver, and muscle values also were relatively constant for 60 min, but lower than that of the heart. The kidney showed an extremely high concentration at 2 min, which then decreased rapidly over time. In rat studies, the heart concentration was also high at two minutes (3.05 ± 0.16 % ID/g) and remained almost constant for 60 min. The heart-to-blood ratios were 93 and 154 at 30 and 60 min, respectively. The distribution pattern was nearly identical to that of the murine study. The in vivo biodistribution of 14 C-TPMP demonstrated that the cation first became concentrated in the myocardium and then remained constant with high heart to-blood ratios. The 14 C-TPMP concentration in the kidney was initially high and then decreased rapidly [21] . High radioactivity was observed in the urinary bladder, and relatively high activity in the lumen of the intestine. These results suggest that 14 C-TPMP is excreted mainly through the kidney and, to some extent, through the hepatobiliary system, because a high gallbladder concentration was observed in the preliminary study. Hepatobiliary secretion of the cation may interfere with interpretation of heart images adjacent to the liver. However, the heart-to-liver ratios were higher than two in murine studies with heart imaging. 18 F-TPP demonstrated an 11-fold higher accumulation in the heart at five minutes (1.64 % ID/g) relative to the blood and a five-fold higher accumulation relative to the liver [25] . At 30 min, the radioactivity in the heart was 1.51 % ID/g and the heart-to-blood ratio was 75. Blood activity changed significantly from 5 to 60 minutes, dropping from 0.15 to 0.02 % ID/g. At 5, 30, and 60 minutes, lung activity was 0.69, 0.36, and 0.38 % ID/g, respectively, whereas liver uptake was 0.34, 0.18, and 0.17 % ID/g, respectively. Heart-to-lung ratios at 5, 30, and 60 minutes were 2, 5, and 4, respectively. Bone accumulation, an indication of defluorination, was minimal: 0.33 % ID/g at 5 minutes and 0.39 % ID/g at 60 minutes.
Among 3-18 F-fluoropropyltriphenylphosphonium, 18 FFBnTP, and 4-18 F-fluorobenzyltris 4-dimethylamino phenylphosphonium cations, murine biodistribution was reported only for 18 F-FBnTP [16] . 18 F-FBnTP biodistribution in mice was organ specific, with the strongest uptake in the kidney, followed by the heart and liver, and very low uptake in the lung at 60 min. 18 F-FBnTP demonstrated a 240-fold higher accumulation in the heart at 60 minutes (12.16 % ID/ g) relative to the blood (0.05 % ID/g) and a 1.5-fold higher accumulation relative to the liver (8.09 % ID/g). 18 F-FATPs showed superior heart-specific uptake and wash out from liver than those reported for radioisotope labeled TPP derivatives with modifications of lipophilicity and functional groups of Table 3 . Although there is little information available with regard to the optimal lipophilicity needed for high myocardial selectivity, cationic radiotracers with log P values in the range of 0.5-1.3 are particularly useful for imaging organs with high mitochondrial density as a result of their fast membranepenetration kinetics [36] . Furthermore, the lipophilic interaction between the triphenylphosphonium cation and the lipid layer is attractive because the alkyl group increases lipophilicity [38, 39] . In vivo biodistribution of 18 F-FATPs was examined in BALB/c mice at 10, 30, 60, and 120 minutes after intravenous injection. A high level of radioactivity accumulation in the heart with rapid clearance from the liver and blood. The myocardial uptake of 18 F-FATPs was more than 20 % ID/g at 10, 30, 60, and 120 minutes after radiotracer injection. The heart-to-liver ratio and heart-to-blood ratio was over 4 and 30 , respectively, at 10 minutes. However, clearance of 18 F-FETMP from the liver occurred later than for other organs due to the methoxy functional group of triphenylphosphonium (heart-to-liver ratio at 10 min: 2.33 ± 0.36).
PET imaging studies of 18 
PET imaging studies of 11 C-TPMP were performed in normal dog models [21, 41] .
11
C-TPMP concentrated in the myocardium within a few minutes with very rapid clearance from the blood. The concentration varied from 0.038 to 0.082 % dose/ ml and the heart-to-blood ratios were 28-53 and 49-105 at 20 and 60 minutes, respectively. In addition, these studies measured the 11 C-TPMP concentration in the heart after injection of potassium chloride, which resulted in a reduced heart rate, arrhythmia, and ventricular fibrillation. When ventricular fibrillation occurred, a decrease of about 40-50 % in the 11 C-TPMP concentration was observed. The rapid decrease of 11 C-TPMP might indicate an irreversible depolarization of the myocardium.
In vivo characterization of 18 F-TPP was performed in normal rat and coronary occlusion rabbit models. 18 F-TPP showed intense cardiac uptake with an initial spike in activity corresponding to blood flow followed by a plateau after 1-2 min. The cardiac uptake was 1.5 % ID/g in rats, which is in the range for that of 99m Tc-tetrofosmin or -sestamibi. The time-activity curve (TAC) generated from PET imaging of rats showed that 18 F-TPP uptake by the heart wall was approximately two-fold higher than blood uptake for 60 minutes. Similarly, rabbit images indicated rapid blood clearance and clear delineation of the plateau of heart activity for the hourlong scanning period. The uptake and kinetics of 18 F-FBnTP were evaluated in murine and normal canine models. 18 FFBnTP is metabolically stable and demonstrated excellent characteristics as a cardiac imaging agent in both models. The myocardium-to-liver uptake ratio in the TAC reached 1 at approximately 25 minutes after intravenous injection of 18 FFBnTP in mice. Furthermore, the myocardium-to-liver uptake ratio was 1 in dog models for 90 minutes after 18 F-FBnTP injection. 18 F-FATPs showed excellent heart-background contrast in microPET imaging of murine models at each time point and afforded better in vivo characterization than 13 N-NH 3, which is the clinical gold standard myocardial imaging agent for PET [28] [29] [30] [31] 34] . Static microPET images of normal rats after intravenous (i.v.) injection of 18 F-FATPs or 13 N-NH 3 are shown in Fig. 3 . The 18 F-FATP images demonstrated good visualization of the heart, with excellent heart-to-liver and heart-to-lung discrimination and high contrast between the myocardium and liver or lung. By contrast, 13 N-NH 3 images showed higher liver uptake than heart uptake until 30 minutes after tracer injection. Intense liver uptake, caused by prominent hepatobiliary excretion, is frequently observed on 99m Tcbased myocardial imaging [42, 43] . High liver uptake is the cause of photon scatter that may mask the detection of flow abnormalities, particularly in the inferior and inferoapical left ventricular wall [43, 44] . The F-FETP were 1.67 ± 0.21, 2.49 ± 0.08, and 2.6 ± 0.85, respectively, whereas myocardium-to-lung ratios were 3.65 ± 0.2, 5.67 ± 0.52, and 6.31 ± 0.8, respectively, 1 minutes after i.v. injection. By contrast, 13 N-NH 3 TAC revealed that the myocardium-to-liver ratio and the myocardium-to-lung ratio were 0.8 ± 0.14 and 0.93 ± 0.07, respectively at 5 minutes after injection. Thereafter, liver and lung uptake of 13 N-NH 3 was higher than that of the myocardium. The myocardium-to-liver ratios of 18 F-FPTP, 18 F-FHTP, and 18 F-FETP were over seven-, 17-, and ten-fold higher, whereas myocardium-to-lung ratios were two-, three-, and three-fold higher, respectively, than those of 13 N-NH 3 at 30 minutes after injection. On the basis of the TAC from microPET images, 18 F-FATPs demonstrated high heart-to-liver and heart-to-lung ratios 10 minutes after injection. These results are consistent with the high-quality myocardial images obtained with N-NH 3 (10 min). However, the 13 N-NH 3 images significantly underestimated infarct size early after tracer injection (0-10 min, P = 0.027), which might be due to spillover of radioactivity into the left ventricular or right ventricular myocardium [34] . To confirm the spillover effect of 13 N-NH 3 early after i.v. injection, we compared polar map images acquired from zero to three minutes and three to six minutes. The defect size and contrast ratio of 13 N-NH 3 images at zero to three minutes were significantly lower than those at three to six minutes (P = 0.043), whereas 18 F-FATPs showed similar values for defect size and contrast ratio at zero to three and three to six minutes. The defect size for MI generated from microPET polar map imaging of 18 F-FPTP or 13 N-NH 3 was compared with 2,3,5-triphenyltetrazolium chloride (TTC) staining to measure the coefficient of determination [33] . The correlation coefficient between TTC staining and the polar map of 
Perfused Isolated Rat Heart Study
The first-pass extraction fraction (EF) values of 18 F-FATPs or 13 N-NH 3 were measured in isolated rat hearts perfused by the Langendorff method [34] . Despite the limitations of the Langendorff method, including the absence of normal humoral influences and neuronal regulation, a variety of cardiovascular researchers still use this technique because it has many advantages, such as simplicity, measurement accuracy, high reproducibility, and relatively low cost [45] . EF values for all flow rates are shown in Table 4 . Lower EFs were found at higher flow rates, which was true for both demonstrated a significantly lower EF value than 13 N-NH 3 at a flow velocity of 0.5 mL/min. The flow rate tested in this study (0.5-16 mL/min) would be relevant because the expected flow rate of the Langendorff method is 7-9 mL/minutes for rats and the MBF of normal rats under isoflurane anesthesia is 4.2 ± 0.9 mL/minutes [46] . Generally, flow rates in isolated rat hearts are considerably higher than those under physiologic conditions and lower EFs have been found at higher flow rates. Thus, perfusion tracers showed considerably lower values in the isolated heart model [7] . The SPECT agent 99m Tc-sestamibi demonstrated an average myocardial EF of 38 % (SD = 9 %) for a flow range of 0.52-3.19 mL/min/g in isolated rabbit hearts. In another study, 82 Rb exhibited a value of 42 % (SD = 6 %), which was observed after injection into the femoral vein of mongrel dogs at normal resting flow rates (0.75-1.5 mL/min/g) [47, 48] 
Limitations
Some limitations of radiolabeled TPP derivatives should be considered in view of the results so far achieved. First, although the results using radiolabeled TPP derivatives suggest that the agents used in the current preclinical studies may be suitable for clinical studies (because of the stable uptake and excellent pharmacokinetics), these results were obtained only in an experimental study using small animal models. Further preclinical application is being evaluated using a pig model that more closely resembles the human heart in its size, heart rate, myocardial blood flow, and mitochondrial density. Second, these results were limited to acute MI with permanent LCA ligation. This model is well-suited to determine myocardial defects but is not identical to the clinical situation in which hemodynamically relevant stenosis is unmasked by a stress-induced increase of myocardial blood flow. Further studies are needed to validate radiolabeled TPP derivatives for the detection of small areas of myocardial ischemia and scars from chronic infarctions.
Clinical Perspective and Conclusion
Despite numerous groundbreaking advances in the field, cardiovascular disease (CVD) remains the leading cause of mortality and morbidity worldwide [49, 50] . Cardiac PET imaging with novel radiotracer can display biological processes directly at the cellular and molecular level within the intact and living heart, and is becoming an indispensable tool in CVD diagnosis. The excellent performance of radiolabeled TPP derivatives as mitochondrial voltage sensors suggests their suitability for detecting CVD. This hypothesis is supported by previously reported studies that evaluated in vivo characterization of these agents in animal models. Among radiolabeled TPP derivatives, 18 F-FATPs provided excellent cardiac PET image quality. In vivo characteristics of 18 FFATPs was significantly better than the current gold standard tracer, 13 N-NH 3 . In addition, 
